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Summary The relationship between Quetelet's index and subsequent risk for cancer of endocrine target
organs was studied in a cohort of 47,003 women, examined for height and weight in the years 1963-65, and
followed up in the Swedish Cancer Register until 1987. High Quetelet's index was associated with a decreased
risk for breast cancer among women less than 55 years of age at risk, while a high Quetelet's index predicted
an increased risk among older women. Among women > 55 years of age, the excess relative risk for breast
cancer associated with high Quetelet's index declined significantly during the follow-up period. Cancer of the
ovaries and the uterine cervix were not significantly related to Quetelet's index in any age group. In women
> 55 years of age, the relative risk for cancer of the uterine corpus associated to Quetelet's index was higher
than that for breast cancer, and this association persisted during the entire follow-up period of more than 20
years. In spite of the fact that endometrial cancer is less common than breast cancer, because of the stronger
relation between overweight and endometrial cancer, more endometrial cancer would be attributable to obesity
than breast cancer.
In correlational studies on cancer incidence in different coun-
tries, cancers of the female endocrine target organs, i.e.
breast, cervix uteri, corpus uteri and ovary, have similar
international distributions, which could indicate common
aetiological factors (Parkin, 1989; Albanes & Taylor, 1990).
Overweight, often described by a high Quetelet's index
(kg m-2), has been described as a risk factor for all of the
above-mentioned cancer sites (Lew & Garfinkel, 1979; Gar-
finkel, 1986; Folsom et al., 1989; La Vecchia et al., 1991).
Breast cancer and Quetelet's index has been extensively
studied, and negative correlations among premenopausal
women and positive correlations among post-menopausal
women have been the dominant findings (de Waard, 1975;
Willet et al., 1985; Le Marchand et al., 1988; Tornberg et al.,
1988; London et al., 1989; Vatten & Kvinnsland, 1990).
Cancer of the uterine corpus, i.e. endometrial cancer, shows a
strong positive correlation with overweight among both
premenopausal and post-menopausal women (La Vecchia et
al., 1984, 1991; Tretli & Magnus, 1990). Weight gain and
body fat pattern also seem to play a role in endometrial
carcinogenesis (Le Marchand et al., 1991), at least among
post-menopausal women. Cancer of the ovaries and cervix
has also been associated with overweight (Garfinkel, 1986;
Farrow et al., 1989; Slattery et al., 1989), which however, for
ovarian cancer, has not been confirmed in all studies (Szam-
borski et al., 1981; Shu et al., 1989).
In the relationships between overweight and hormone-
dependent cancers, differences have been described for
premenopausal and post-menopausal women. Thus it
appears that menopausal status, i.e. levels of oestrogen and
progesterone, play a role in the relationships between cancer
risk and Quetelet's index (de Waard, 1975; Adami et al.,
1977; La Vecchia et al., 1984; Tornberg et al., 1988; Le
Marchand et al., 1988; 1991; Folsom et al., 1989; 1990;
London et al., 1989; Tretli, 1989; Tretli & Magnus, 1990;
Levi et al., 1992).
In a previous study of this cohort of more than 47,000
women, we found an increased risk for breast cancer among
obese post-menopausal women (Tornberg et al., 1988). The
aim of the present study was to analyse and compare the risk
for endocrine-related cancers, i.e. cancer of the ovaries, the
cervix uteri, the endometrium and the breast, in relation to
Quetelet's index in a large cohort of women followed for up
to 25 years.
Material and methods
A general health screening programme was conducted in two
counties in central Sweden, and all individuals 25 years of
age or more were invited to take part (National Board of
Health and Welfare, 1971). Nearly 80% participated and
were examined for, among other parameters, height and
weight during the period 1963-65. The mean age was 48
years. No data were available on parity, menopausal status,
dietary habits or tobacco consumption. The analyses have
been restricted to those 47,003 women who were <75 years
of age at entry into the study, and in whom weight and
height were measured.
The data from the survey were stored on magnetic tape
and the cohort was matched with the nationwide Swedish
Cancer Register (Mattsson & Wallgren, 1984) and the
nationwide Swedish Cause of Death Register. The registers
were searched for all reports on malignant diseases and for
date of death, until 31 December 1987. This data linkage was
made possible as a result of the identification numbers used
in all Swedish population statistics. Each individual in
Sweden is assigned a unique identification number consisting
of ten digits indicating year, month and day of birth, supple-
mented by four digits indicating the region of birth and sex
and one control digit. The numbers are not affected by name
changes or changes in marital status.
The mean body mass index (BMI) was 24.9 kg m2 and
the standard deviation was 3.9. The women were grouped
into five categories of almost equal size (quintiles) with
respect to their Quetlet's index. Owing to the lack of data on
menopausal status, the cohort was also divided in groups of
<55 and > 55 years of age at risk of cancer.
The risk relationships between cancers of the breast,
endometrium, ovaries and uterine cervix and Quetelet's index
categories were analysed using the log-linear Poisson regres-
sion model (Breslow & Day, 1987). In the analysis, adjust-
ments were made for age at risk (5-year groups) and period
of follow-up (5-year groups).
Results
During the period of follow-up, 2,479 cancers of endocrine
target organs were found in the cohort: 330 ovarian cancers,
412 cancers of the uterine corpus, 271 cancers of the uterine
cervix and 1,466 breast cancers. Only the first reported
cancer of the ovary, corpus uteri, cervix of breast, among
those women reported has having more than one cancer,
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were included in the study. The total number of person-years
at risk was 956,185. The number of person-years at risk for
each category of Quetelet's index is shown in Table I.
The risk of breast cancer was negatively correlated with
Quetelet's index among women <55 years, whereas obese
women > 55 years of age had an increased risk of breast
cancer (Table II). The difference in average increase in
relative risk of breast cancer (for each Quetelet's index
category) between the two age groups, 1.05 vs 0.86, was also
significant (P = 0.013). There were no significant risk rela-
tionships between Quetelet's index and cervical cancer or
ovarian cancer. The risk for endometrial cancer increased
with increasing Quetelet's index category, although the trend
was significant only for women 55 years of age or older
(Table II).
The relative risk for endometrial cancer in relation to
overweight, among women > 55 years of age at risk, was
significantly higher (P<0.0001) than the corresponding
relative risk for breast cancer.
The positive risk relationship between Quetelet's index and
breast cancer among women > 55 years of age was limited to
the first two periods of follow-up (Figure 1), and the declin-
ing relative risk with follow-up time was also statistically
significant (P = 0.041). The corresponding relative risk for
endometrial cancer was consistent and significantly correlated
to Quetelet's index during almost all periods of follow-up
(Figure 1).
Discussion
We found increased risks for breast cancer and endometrial
cancer among obese women > 55 years of age. The findings
Table I The number of women and the number of person-years at
risk for each Quetelet's index category
Quetelet's Number Person-years by age at risk
index of
category women <55 > 55 All
<22 10.675 149,603.1 78,540.6 228,143.7
22-23.9 10.060 105,242.9 105,753.1 210,996.0
24-25.9 9,723 75,604.4 123,046.3 198,650.7
26-27.9 7,160 42,750.1 98,077.3 140,827.4
> 28 9,385 44,377.4 133,189.7 177,567.1
All 47,003 417,577.9 538,607.0 956,184.9
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Figure 1 Age-adjusted relative risk (RR) of breast cancer (solid
circles) and cancer of the uterine corpus (open circles) for each
Quetelet's index category for different periods of follow-up.
Ninety-five per cent intervals are shown.
were in accordance with those described by others (de
Waard, 1975; Elwood et al., 1977; La Vecchia et al., 1984;
Willett et al., 1985; Le Marchand et al., 1988; Tornberg et
al., 1988; Folsom et al., 1989; London et al., 1989; Tretli,
1989; Tretli & Magnus, 1990; Vatten & Kvinnsland, 1990).
However, the large differences in relative risk for breast and
endometrial cancer according to Quetelet's index and the
declining relative risk with length of follow-up for post-
menopausal breast cancer in relation to Quetelet's index
have, to our knowledge, not been described before. In most
studies on the present subject, shorter follow-up periods or
fewer cancer patients were included in the analysis, which
limits a comparison with the present study.
The differences in relative risks for breast cancer and
endometrial cancer in relation to Quetelet's index and the
declining trend in relative breast cancer risk were statistically
significant and could therefore not be explained by random
effects only. Since there is only a single measurement
available, we have not been able to account for any changes
in Quetelet's index before or after the screening examination.
Table II Age-adjusted relative risk (RR) of cancer at difference sites according to Quetelet's index category, by age group'
Cancer site Quetelet's index (kgm-2) RR per
Test Quetelet's
for index
Age at risk <22 22-23.9 24-25.9 26-27.9 ) 28 trend category 95% CI
Breast
<55 1.00 (154) 0.69 (84) 0.65 (61) 0.92 (50) 0.41 ( 24) P = 0.0004 0.86 0.80-0.94
> 55 1.00 (148) 0.94 (190) 0.97 (231) 1.18 (228) 1.13 (296) P= 0.021 1.05 1.01-1.10
Total 1.00 (302) 0.82 (274) 0.83 (292) 1.05 (278) 0.92 (320) P = 0.73 1.01 0.97-1.05
Cervix
<55 1.00 (46) 0.71 (25) 0.91 (24) 0.72 (11) 1.09 (18) P= 1.00 1.00 0.88-1.15
> 55 1.00 (24) 1.07 (34) 0.88 (32) 0.94 (27) 0.77 (30) P = 0.25 0.93 0.83-1.05
Total 1.00 (70) 0.90 (59) 0.90 (56) 0.87 (38) 0.87 (48) P = 0.48 0.97 0.88-1.06
Endometrium
< 55 1.00 (23) 1.06 (21) 1.06 (17) 0.72 (7) 1.64 (18) P = 0.33 1.08 0.92-1.27
> 55 1.00 (24) 1.52 (48) 2.05 (74) 2.17 (61) 3.16 (119) P<0.0001 1.29 1.19-1.40
Total 1.00 (47) 1.30 (69) 1.64 (91) 1.65 (68) 2.55 (137) P<0.0001 1.24 1.16-1.34
Ovary
<55 1.00 (24) 1.44 (28) 1.06 (16) 1.35 (12) 1.66 (16) P= 0.23 1.10 0.95-1.27
> 55 1.00 (41) 0.96 (53) 0.67 (43) 0.72 (37) 0.87 (60) P = 0.32 0.95 0.87-1.05
Total 1.00 (65) 1.15 (81) 0.81 (59) 0.91 (49) 1.08 (76) P= 0.89 1.00 0.92-1.08
aNumber of cases is given within parentheses.360 S.A. TORNBERG & J.M. CARSTENSEN
Thus, the risk estimates are probably underestimated, though
the extent of this underestimation is difficult to quantify.
Both the breast and the endometrial mucosa are target
organs for sex hormones, i.e. oestrogen and progesterone,
and there are different mechanisms suggested for increased
levels of oestrogen among obese post-menopausal women
(Siiteri, 1987; Boman et al., 1990). Obesity makes more
androgen precursors available for conversion to oestrogen in
peripheral tissues, and adipose tissue is the major tissue site
of that conversion. Plasma levels of sex hormone-binding
globulin (SHBG) are depressed in obese subjects, resulting in
an increased level of free oestrogen and an increased effect on
the target cells. This hypothesis does not explain the
differences in relative risk between breast cancer and
endometrial cancer in relation to Quetelet's index. However,
the differences must be due to different effects of oestrogen in
breast tissue and on the endometrial mucosa.
Breast cancer and endometrial cancer show differences in
incidence rates in different age groups (National Board of
Health and Welfare, 1991). Endometrial cancer has its
incidence maximum around the age of 60 and shows a slow
decrease thereafter. In contrast, breast cancer incidence
steadily increases with age. Endometrial cancer could be less
common before menopause because of the protective effect of
progesterone (Parazzini et al., 1991). After the menopause
this protective effect is lost, making a carcinogenic effect of
oestrogen dominant. In contrast, breast cancer is also a
common disease among premenopausal women and oestro-
gen is believed to have a promoting effect in the breast tissue.
In a large prospective study of women receiving hormone
replacement therapy it was shown that the risks were in-
creased for both endometrial cancer and breast cancer, and
also that the excess relative risk was higher for endometrial
cancer than for breast cancer (Adami et al., 1989; Bergkvist
et al., 1989). One reason for relative risk of breast cancer
being lower than the relative risk for endometrial cancer in
relation to Quetelet's index could be that oestrogen does not
affect oestrogen receptor (ER)-negative breast cancers, and
the effect of overweight, i.e. increased oestrogen level, was
limited to ER-positive breast cancers during the first years of
follow-up. In spite of the fact that the incidence of endomet-
rial cancer is lower than for breast cancer, a larger number of
endometrial cancers, in absolute terms, would be attributable
to obesity than breast cancer according to the present
findings.
This study confirms previously described findings of
positive correlations between obesity and cancer of the breast
and the endometrium among older women. However, the
clear-cut effect of obesity on endometrial cancer risk, a risk
that was stable for the entire follow-up period, and its lesser
effect on relative breast cancer risk, suggests different
aetiological mechanisms. It seems that the above-described
mechanism of altered post-menopausal hormonal homeo-
stastis due to obesity, in which additional oestrogen is pro-
duced in adipose tissue, is a major mechanism for increased
risk of endometrial cancer.
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